STING Pathway Blocks Flu Virus From Jumping to Humans

A Built-In Defense Against Pandemic Flu

Researchers have identified a previously unknown immune mechanism that helps prevent influenza viruses from jumping from animal hosts to humans, a process known as zoonotic spillover. The study, published in Science, reveals that the STING-NF-kappaB signaling pathway in human cells acts as a natural barrier against animal-origin influenza strains, providing a new understanding of why most flu viruses that circulate in birds and pigs fail to establish sustained transmission in human populations.

The discovery has significant implications for pandemic preparedness, as influenza pandemics occur when an animal flu virus acquires the ability to overcome species barriers and spread efficiently among humans. Understanding the molecular defenses that normally prevent this crossover could lead to new strategies for predicting and preventing the next pandemic.

The STING Pathway

STING, which stands for Stimulator of Interferon Genes, is a protein that plays a central role in the innate immune system's ability to detect and respond to infections. It has been extensively studied for its role in defending against DNA viruses and bacterial infections, but its involvement in defending against influenza — an RNA virus — was not previously well understood.

The new research shows that when animal-origin influenza viruses attempt to replicate in human cells, their replication process triggers activation of the STING pathway. This activation leads to signaling through NF-kappaB, a master regulator of inflammatory and immune gene expression, which in turn launches a potent antiviral response that suppresses viral replication before it can establish a productive infection.

Critically, the researchers found that influenza viruses that have already adapted to humans have evolved mechanisms to evade or suppress STING-mediated detection. This means that the STING pathway acts as a selective filter: animal viruses that have not yet evolved evasion strategies are blocked, while adapted human viruses pass through.

Why Some Viruses Break Through

The discovery raises an important question: if STING provides a barrier against animal flu viruses, what allows some viruses to overcome it and cause pandemics? The researchers found that certain mutations in viral proteins can reduce or eliminate STING activation, essentially rendering the virus invisible to this particular branch of the immune system.

These evasion mutations appear to be one of the key adaptations that an animal flu virus must acquire to become capable of sustained human-to-human transmission. The researchers identified specific amino acid changes in influenza proteins that correlate with the ability to suppress STING signaling, providing potential molecular markers that could be used to assess the pandemic risk of circulating animal flu strains.

This finding could enhance existing surveillance systems that monitor influenza viruses in bird and pig populations for signs of pandemic potential. Currently, surveillance focuses primarily on changes in the viral hemagglutinin protein that affect binding to human airway cells. Adding STING evasion mutations to the monitoring criteria could provide an additional early warning signal that a virus is acquiring the adaptations needed for human spread.

Implications for Pandemic Preparedness

The identification of a specific molecular barrier to influenza spillover opens several avenues for pandemic prevention research. One approach would be to develop therapeutic agents that enhance STING pathway activity in human respiratory cells, effectively raising the height of the barrier that animal viruses must overcome to establish infection.

Another approach could involve using knowledge of STING evasion mechanisms to design vaccines that prime the immune system to recognize and target the specific viral features associated with spillover adaptation. Such vaccines could potentially provide protection against pandemic strains before they emerge, by targeting the conserved changes that viruses must make to cross the species barrier.

The research also has implications for understanding the risk posed by the H5N1 avian influenza virus, which has been spreading among dairy cattle in the United States and has caused sporadic human infections. Assessing whether circulating H5N1 strains have acquired STING evasion mutations could provide valuable information about the virus's pandemic potential.

Beyond Influenza

The STING pathway's role as a spillover barrier may extend beyond influenza to other zoonotic viruses. Many of the most concerning emerging infectious disease threats, including coronaviruses, henipaviruses, and paramyxoviruses, originate in animal reservoirs and must overcome species-specific immune defenses to infect humans.

Understanding how innate immune pathways like STING-NF-kappaB function as species barriers could provide a unified framework for assessing and mitigating zoonotic disease risks across multiple viral families. This broader perspective on spillover biology represents a shift from studying individual viruses in isolation to understanding the general principles that govern cross-species transmission.

The study adds to a growing body of research that positions innate immunity, rather than adaptive immunity, as the primary determinant of species barriers to viral transmission. While adaptive immune responses are critical for fighting established infections, the innate immune system's ability to rapidly detect and respond to unfamiliar pathogens appears to be the first and most important line of defense against spillover events.

This article is based on reporting by Science (AAAS). Read the original article.